|
Volumn 11, Issue 3, 2000, Pages 13-17
|
Impedance cardiography (ICG) noninvasive hemodynamic monitoring provides an opportunity to deliver cost effective, quality care for patients with cardiovascular disorders.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CARDIOVASCULAR DISEASE;
COST BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEM;
ECONOMICS;
HEALTH CARE QUALITY;
HEMODYNAMICS;
HUMAN;
IMPEDANCE CARDIOGRAPHY;
METHODOLOGY;
MONITORING;
REPRODUCIBILITY;
STANDARD;
UNITED STATES;
CARDIOGRAPHY, IMPEDANCE;
CARDIOVASCULAR DISEASES;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEMS, CLINICAL;
HEMODYNAMIC PROCESSES;
HUMANS;
MONITORING, PHYSIOLOGIC;
QUALITY OF HEALTH CARE;
REPRODUCIBILITY OF RESULTS;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
UNITED STATES;
|
EID: 0034182936
PISSN: 10535330
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|